North Wales, PA, United States of America

Indu Shah

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mcneil-Ppc, Inc.. Active years: 2013.


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Indu Shah: Innovator in Pharmaceutical Tablet Production

Introduction

Indu Shah is a notable inventor based in North Wales, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the production of cetirizine tablets. Her innovative methods have the potential to enhance the efficiency and effectiveness of tablet manufacturing.

Latest Patents

Indu Shah holds a patent for a method of making cetirizine tablets. This patent outlines a process that includes several key steps: mixing cetirizine with a polyol and a solvent to create a cetirizine:polyol complex, isolating the particles from the mixture, and finally forming these particles into a tablet. This method is designed to optimize the production of cetirizine tablets, which are commonly used as antihistamines.

Career Highlights

Throughout her career, Indu Shah has worked with prominent companies such as McNeil-PPC, Inc. and Johnson & Johnson Consumer Inc. Her experience in these organizations has allowed her to develop and refine her innovative approaches to pharmaceutical manufacturing.

Collaborations

Indu has collaborated with several professionals in her field, including Kenneth Day and Kangping Xiao. These partnerships have contributed to her success and the advancement of her patented methods.

Conclusion

Indu Shah's contributions to the pharmaceutical industry, particularly through her patent for cetirizine tablet production, highlight her role as an innovator. Her work continues to influence the field and improve the manufacturing processes of essential medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…